| Adaptive Processes Change as Multiple Functions Evolve. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Monitoring the epidemiology and antifungal resistance of yeasts causing fungaemia in a tertiary care hospital in Madrid, Spain. Any relevant changes in the last 13 years? | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| The Role of New Posaconazole Formulations in the Treatment of Candida albicans Infections:Data from an in Vitro Pharmacokinetic-Pharmacodynamic Model. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Limited MDR efflux pump overexpression among multidrug-resistant Escherichia coli of ST131. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| In-Vitro Study of the Synergistic Effect of an Enzyme Cocktail and Antibiotics against Biofilms in a Prosthetic Joint Infection Model. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Physicochemical and Structural Parameters Contributing to the Antibacterial Activity and Efflux Susceptibility of Small Molecule Inhibitors of Escherichia coli. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Identification of Antifungal Compounds against Multidrug Resistant Candida auris Utilizing a High Throughput Drug Repurposing Screen. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Ethylzingerone, a Novel Compound with Antifungal Activity. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Variability of Hydroxy-Itraconazole in Relation to Itraconazole Bloodstream Concentrations. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Characterization of an IncFIB/IncHI1B plasmid encoding efflux pump TMexCD1-TOprJ1 in a clinical tigecycline and carbapenem-resistant Klebsiella pneumoniae strain. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| The benzimidazole SPR719 shows promising concentration-dependent activity and synergy against nontuberculous mycobacteria. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Semi-mechanistic pharmacokinetic and pharmacodynamic modelling of piperaquine in a volunteer infection study with Plasmodium falciparum blood-stage malaria. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Therapeutic potential of Fosmanogepix (APX001) for intra-abdominal candidiasis: from lesion penetration to efficacy in a mouse model. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Tetracycline resistance mediated by tet(M) has variable Integrative Conjugative Element composition in Mycoplasma hominis isolated in the United Kingdom from 2005-2015. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| In vivo targeting of E. coli with vancomycin-arginine. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Deletion of PknG abates reactivation of latent Mycobacterium tuberculosis in mice. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Synergistic rifabutin and colistin reduce emergence of resistance when treating Acinetobacter baumannii. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Assessment of piperacillin-tazobactam-meropenem synergy against serine carbapenemase producing Enterobacterales using time kill assays. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Boromycin has potent anti-Toxoplasma and anti-Cryptosporidium activity. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Identification of Tn6835 and a Novel Genomic Island MMGI-1 in a Pan-Resistant Morganella morganii Strain. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Daptomycin resistance in Enterococcus faecium can be delayed by disruption of the LiaFSR stress response pathway. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| The antibiotic negamycin crosses the bacterial cytoplasmic membrane by multiple routes. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| In vitro resistance and evolution of resistance to tavaborole in Trichophyton rubrum. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Dose-fractionation of moxifloxacin for the treatment of tuberculosis: impact of dosing interval and elimination half-life on microbial kill and resistance suppression. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Carbapenem use is driving the evolution of IMiPenemase (IMP)-1 variants. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| The Pup-Proteasome System Protects Mycobacteria from Antimicrobial Antifolates. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Modulation of Human Beta-Defensin 2 Expression by Pathogenic Neisseria meningitidis and Commensal Lactobacilli. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral or Thymol with anti-Candida Activities. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Electrostatic-Mediated Affinity Tuning of Lysostaphin Accelerates Bacterial Lysis Kinetics and Enhances in Vivo Efficacy. | Antimicrobial Agents and Chemotherapy | 2 days | save |  |  |  |  |
| Activity of Clofazimine and TBI-166 against Mycobacterium tuberculosis, in different administration intervals in mouse tuberculosis models. | Antimicrobial Agents and Chemotherapy | 10 days | save |  |  |  |  |
| Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterisation of Candida auris Detected in a Surveillance Program. | Antimicrobial Agents and Chemotherapy | 10 days | save |  |  |  |  |
| Analysis of multidrug resistance in Staphylococcus aureus with a machine learning generated antibiogram. | Antimicrobial Agents and Chemotherapy | 10 days | save |  |  |  |  |
| In Vivo Activity of WCK 4282 (High-Dose Cefepime/Tazobactam) against Serine-β-lactamase-Producing Enterobacterales and Pseudomonas aeruginosa in the Neutropenic Murine Lung Infection Model. | Antimicrobial Agents and Chemotherapy | 10 days | save |  |  |  |  |
| Activity of Cefepime in Combination with the novelß-Lactamase inhibitor taniborbactam (VNRX-5133) against ESBL-producing isolates in in vitro checkerboard assays. | Antimicrobial Agents and Chemotherapy | 10 days | save |  |  |  |  |
| The C2H2 Transcription Factor SltA Contributes to Azole Resistance by Coregulating the Expression of the Drug Target Erg11A and the Drug Efflux Pump Mdr1 in Aspergillus fumigatus. | Antimicrobial Agents and Chemotherapy | 10 days | save |  |  |  |  |
| Structural and biochemical characterization of the novel CTX-M-151 extended-spectrumβ-lactamase and its inhibition by Avibactam. | Antimicrobial Agents and Chemotherapy | 10 days | save |  |  |  |  |
| Antagonistic Effect of Colistin on Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus in In Vitro and In Vivo Studies. | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase. | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018). | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data? | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Potency of Vaborbactam Is Less Affected than That of Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam. | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of Yersinia pestis. | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Assessment of Tedizolid In Vitro Activity and Resistance Mechanisms against a Collection of Enterococcus spp. Causing Invasive Infections, Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from U.S. and European Medical Centers | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp. | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Clostridioides difficile-Associated Antibiotics Alter Human Mucosal Barrier Functions by Microbiome-Independent Mechanisms. | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Lead Optimization of Dehydroemetine for Repositioned Use in Malaria. | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Ceftazidime-Avibactam Resistance Associated with Increased bla KPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae. | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| A Computer Modelling Approach To Evaluate the Accuracy of Microsatellite Markers for Classification of Recurrent Infections during Routine Monitoring of Antimalarial Drug Efficacy. | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
| Suppression ofβ-Lactam Resistance by Aspergillomarasmine A Is Influenced by both the Metallo-β-Lactamase Target and the Antibiotic Partner. | Antimicrobial Agents and Chemotherapy | 11 days | save |  |  |  |  |
|  report | next » |
|